When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 58 Hits
  • Search Condition : Filter (MeSH = Receptor Activator of Nuclear Factor-kappa B)
Species Resource Title
Human and Animal Cells ST2(RCB0224) Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone.
Human and Animal Cells ST2(RCB0224) IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo.
Human and Animal Cells ST2(RCB0224) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
Human and Animal Cells ST2(RCB224) Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells.
Human and Animal Cells T3M-1 Clone2(RCB1015) , HFL-I(RCB0521) , HL60(RCB0041) Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation.
Human and Animal Cells ST2(RCB0224) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
Human and Animal Cells ST2(RCB0224) IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Human and Animal Cells MC3T3-E1(RCB1126) Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells.
Human and Animal Cells ST2(RCB0224) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Human and Animal Cells RAW 264(RCB0535) Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Human and Animal Cells HL60(RCB0041) , MC3T3-E1(RCB1126) , MC3T3-G2/PA6(RCB1127) , ST2(RCB0224) Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
Human and Animal Cells ST2(RCB0224) Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis.
Human and Animal Cells RAW 264(RCB0535) Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.
Human and Animal Cells ST2(RCB0224) Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Human and Animal Cells RAW 264(RCB0535) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
Human and Animal Cells ST2(RCB0224) Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
Human and Animal Cells RAW 264(RCB0535) Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
Human and Animal Cells ST2(RCB0224) A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation.
Human and Animal Cells NIH3T3-3 Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture.
Human and Animal Cells MG‐63(RCB1890) The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.